Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology
Recruiting
N/A
Interventional Study
Cancer
Prostate Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Health Services Research
- Participants needed
- 207 (estimated)
- Sponsor
- UNC Lineberger Comprehensive Cancer Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This prospective study will test artificial intelligence (AI) and machine learning (ML) decision support tools. This tool is designed to help doctors, physicists and other staff during pre-treatment peer review, a step where treatment plans are checked before a patient begins care.
The system highlights summaries showing how different providers may vary in their treatment planning (provider-varia…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
In order to participate in this study a subject must meet all of the eligibility criteria outlined below.
Inclusion Criteria:
Providers only
* ≥18 years
* Peer-review attendees at participating clinics
Patients only
* ≥18 years
* All patients with prostate cancer radiation therapy cases treated…
Contacts